Literature DB >> 32020371

Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.

Luan Rodrigues Abdallah1, Ricardo Cardoso de Matos1, Yves Pacheco Dias March E Souza1, Débora Vieira-Soares1, Gabriela Muller-Machado1, Priscila Pollo-Flores2.   

Abstract

PURPOSE OF REVIEW: We summarize best data of the association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD). RECENT
FINDINGS: NAFLD has been linked with insulin resistance, obesity, and metabolic syndrome, conditions known to be associated with CVD and subclinical atherosclerosis. The rising evidence of the association between NAFLD and subclinical CVD may suggest that NAFLD is not only a marker but also may be actively involved in pathogenesis of CVD. It is an overview of previous studies assessing relationships between NAFLD and markers of cardiovascular disease, as the presence of coronary artery calcification, increased arterial stiffness, and elevated carotid media thickness, in order to better understand the interplay between these conditions.

Entities:  

Keywords:  Aortic stiffness; Atherosclerosis; Cardiovascular risks; Carotid media thickness; Coronary artery calcification; Inflammation; Non-alcoholic fatty liver disease; Steatohepatitis

Mesh:

Substances:

Year:  2020        PMID: 32020371     DOI: 10.1007/s11883-020-0820-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  57 in total

Review 1.  Mechanisms, pathophysiology, and therapy of arterial stiffness.

Authors:  Susan J Zieman; Vojtech Melenovsky; David A Kass
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02-24       Impact factor: 8.311

2.  Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Michael G Silverman; Michael J Blaha; Harlan M Krumholz; Matthew J Budoff; Ron Blankstein; Christopher T Sibley; Arthur Agatston; Roger S Blumenthal; Khurram Nasir
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

Review 3.  Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.

Authors:  Raul D Santos; Luca Valenti; Stefano Romeo
Journal:  Atherosclerosis       Date:  2019-01-30       Impact factor: 5.162

4.  Brachial-ankle pulse wave velocity in Japanese university students.

Authors:  Akiko Shiotani; Mitsugi Motoyama; Tadayuki Matsuda; Teruo Miyanishi
Journal:  Intern Med       Date:  2005-07       Impact factor: 1.271

5.  Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Luca Scala; Massimo Cigolini; Luciano Zenari; Giancarlo Falezza; Guido Arcaro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-08-22       Impact factor: 4.222

6.  Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.

Authors:  Ebe D'Adamo; Anna M G Cali; Ram Weiss; Nicola Santoro; Bridget Pierpont; Veronika Northrup; Sonia Caprio
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

7.  Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Perrie E Pardee; Joel E Lavine; Aaron K Blumkin; Stephen Cook
Journal:  Circulation       Date:  2008-06-30       Impact factor: 29.690

8.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 9.  Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis.

Authors:  Enea Bonci; Claudio Chiesa; Paolo Versacci; Caterina Anania; Lucia Silvestri; Lucia Pacifico
Journal:  Biomed Res Int       Date:  2015-07-26       Impact factor: 3.411

10.  Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka.

Authors:  Nilanka Perera; Jegarajah Indrakumar; Waruni Vijitha Abeysinghe; Vihangi Fernando; W M C K Samaraweera; Jayamal Sanjaya Lawrence
Journal:  BMC Cardiovasc Disord       Date:  2016-02-12       Impact factor: 2.298

View more
  8 in total

1.  Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.

Authors:  Chenxi Wang; Zhensheng Cai; Xia Deng; Haoxiang Li; Zhicong Zhao; Chang Guo; Panpan Zhang; Lian Li; Tian Gu; Ling Yang; Li Zhao; Dong Wang; Guoyue Yuan
Journal:  Int J Med Sci       Date:  2021-07-23       Impact factor: 3.738

Review 2.  The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.

Authors:  Yuliya I Ragino; Ekaterina M Stakhneva; Yana V Polonskaya; Elena V Kashtanova
Journal:  Biomolecules       Date:  2020-02-28

3.  Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.

Authors:  Chia-Chi Hsiao; Pai-Hsueh Teng; Yun-Ju Wu; Yi-Wen Shen; Guang-Yuan Mar; Fu-Zong Wu
Journal:  BMC Cardiovasc Disord       Date:  2021-05-19       Impact factor: 2.298

4.  Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology.

Authors:  Dandan Peng; Zhenqiu Yu; Mingwei Wang; Junping Shi; Lei Sun; Yuanyuan Zhang; Wenbin Zhao; Chen Chen; Jiake Tang; Chunyi Wang; Jie Ni; Wen Wen; Jingjie Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

5.  Association between non-alcoholic fatty liver disease and risk of incident heart failure: a meta-analysis of observational studies.

Authors:  Wensheng Li; Weixing Wen; Dongxiao Xie; Min Qiu; Xiaoyan Cai; Sulin Zheng; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2022-08-23       Impact factor: 4.970

Review 6.  Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update.

Authors:  Areti Sofogianni; Athanasios Filippidis; Lampros Chrysavgis; Konstantinos Tziomalos; Evangelos Cholongitas
Journal:  World J Hepatol       Date:  2020-08-27

7.  Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Min-Kyu Kang; Jung-Gil Park
Journal:  Diagnostics (Basel)       Date:  2021-05-10

8.  Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease.

Authors:  Xiaoyan Cai; Lichang Sun; Xiong Liu; Hailan Zhu; Yang Zhang; Sulin Zheng; Yuli Huang
Journal:  Ther Adv Chronic Dis       Date:  2021-06-23       Impact factor: 5.091

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.